LEO Pharma A.S.
Industry / private company
Location:
Ballerup,
Denmark (DK)
ISNI: 0000000110107950
ROR: https://ror.org/05tzrdd39
Show on Map:
Proactive Management with twice-a-week Use of topical Cal/BD Spray Foam Management extends the Effectiveness of the Treatment in Comparison to Reactive Management in Patients with Plaque Psoriasis (2021)
Stein-Gold L, Alonso-Llamazares J, Laws P, Perrussel M, Yamauchi P, Thoning H, Toxvaerd C, Sticherling M
Conference contribution
A phase 4, randomized, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE). (2021)
Pinter A, Hoffmann M, Reich K, Augustin M, Kaplan K, Gudjonsdottir SD, Delvin T, Mrowietz U
Journal article
Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study (2019)
Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS
Journal article
Topical delgocitinib is an efficacious and well tolerated treatment for patients with chronic hand eczema (2019)
Worm M, Bauer A, Elsner P, Mahler V, Molin S, Nielsen TSS
Conference contribution